A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy

by Hasic Telalovic, Jasminka, Pillozzi, Serena, Fabbri, Rachele, Laffi, Alice, Lavacchi, Daniele, Rossi, Virginia, Dreoni, Lorenzo, Spada, Francesca, Fazio, Nicola, Amedei, Amedeo, Iadanza, Ernesto, Antonuzzo, Lorenzo
Published in Diagnostics (Basel) (2021)

Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer

by Biffi, Roberto, Fazio, Nicola, Luca, Fabrizio, Chiappa, Antonio, Andreoni, Bruno, Zampino, Maria Giulia, Roth, Arnaud, Schuller, Jan Christian, Fiori, Giancarla, Orsi, Franco, Bonomo, Guido, Crosta, Cristiano, Huber, Olivier
Published 2010

Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report

by Ungaro, Antonio, Orsi, Franco, Casadio, Chiara, Galdy, Salvatore, Spada, Francesca, Cella, Chiara Alessandra, Tonno, Clementina Di, Bonomo, Guido, Vigna, Paolo Della, Murgioni, Sabina, Frezza, Anna Maria, Fazio, Nicola
Published in Ecancermedicalscience (2016)

A single-institution retrospective analysis of metachronous and synchronous metastatic bronchial neuroendocrine tumors

by Peri, Marta, Botteri, Edoardo, Pisa, Eleonora, De Marinis, Filippo, Ungaro, Antonio, Spada, Francesca, Grana, Chiara Maria, Gasparri, Roberto, Spaggiari, Lorenzo, Romentz, Nicole, Badalamenti, Giuseppe, Russo, Antonio, Fazio, Nicola
Published in J Thorac Dis (2018)

Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinica...

by Lambert, Jérémy, Marrel, Alexia, D’Angelo, Sandra P., Burgess, Melissa A., Chmielowski, Bartosz, Fazio, Nicola, Gambichler, Thilo, Grob, Jean-Jacques, Lebbé, Céleste, Robert, Caroline, Russell, Jeffrey, Güzel, Gülseren, Bharmal, Murtuza
Published in Patient (2020)

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

by Buzzoni, Roberto, Carnaghi, Carlo, Strosberg, Jonathan, Fazio, Nicola, Singh, Simron, Herbst, Fabian, Ridolfi, Antonia, Pavel, Marianne E, Wolin, Edward M, Valle, Juan W, Oh, Do-Youn, Yao, James C, Pommier, Rodney
Published in Onco Targets Ther (2017)

Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center

by Rotundo, Maria Saveria, Zampino, Maria Giulia, Ravenda, Paola Simona, Bagnardi, Vincenzo, Peveri, Giulia, Dell’Acqua, Veronica, Surgo, Alessia, Trovato, Cristina, Bottiglieri, Luca, Bertani, Emilio, Petz, Wanda Luisa, Fumagalli Romario, Uberto, Fazio, Nicola
Published in Ther Adv Med Oncol (2020)

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study

by Berruti, Alfredo, Fazio, Nicola, Ferrero, Anna, Brizzi, Maria Pia, Volante, Marco, Nobili, Elisabetta, Tozzi, Lucia, Bodei, Lisa, Torta, Mirella, D’Avolio, Antonio, Priola, Adriano Massimiliano, Birocco, Nadia, Amoroso, Vito, Biasco, Guido, Papotti, Mauro, Dogliotti, Luigi
Published 2014

Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program

by Grignani, Giovanni, Chiarion Sileni, Vanna, Pinto, Carmine, Depenni, Roberta, Fazio, Nicola, Galli, Luca, Giuffrida, Dario, Carnaghi, Carlo, Ciliberto, Domenico, Corsi, Domenico C., Queirolo, Paola, Benincasa, Elena, Venturini, Filippo, Fazzi, Gennaro, Costa, Nuno, Ascierto, Paolo Antonio
Published in J Transl Med (2021)

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study

by D'Angelo, Sandra P, Lebbé, Celeste, Mortier, Laurent, Brohl, Andrew S, Fazio, Nicola, Grob, Jean-Jacques, Prinzi, Natalie, Hanna, Glenn J, Hassel, Jessica C, Kiecker, Felix, Georges, Sara, Ellers-Lenz, Barbara, Shah, Parantu, Güzel, Gülseren, Nghiem, Paul
Published in J Immunother Cancer (2021)

A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

by FAZIO, NICOLA, BUZZONI, ROBERTO, BAUDIN, ERIC, ANTONUZZO, LORENZO, HUBNER, RICHARD A., LAHNER, HARALD, DE HERDER, WOUTER W., RADERER, MARKUS, TEULÉ, ALEXANDRE, CAPDEVILA, JAUME, LIBUTTI, STEVEN K., KULKE, MATTHEW H., SHAH, MANISHA, DEY, DEBARSHI, TURRI, SABINE, AIMONE, PAOLA, MASSACESI, CRISTIAN, VERSLYPE, CHRIS
Published in Anticancer Res (2016)

The role of multimodal treatment in patients with advanced lung neuroendocrine tumors

by Fazio, Nicola, Ungaro, Antonio, Spada, Francesca, Cella, Chiara Alessandra, Pisa, Eleonora, Barberis, Massimo, Grana, Chiara, Zerini, Dario, Bertani, Emilio, Ribero, Dario, Funicelli, Luigi, Bonomo, Guido, Ravizza, Davide, Guarize, Juliana, De Marinis, Filippo, Petrella, Francesco, Del Signore, Ester, Pelosi, Giuseppe, Spaggiari, Lorenzo
Published in J Thorac Dis (2017)

Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT‐4 lung subgroup analysis

by Fazio, Nicola, Buzzoni, Roberto, Delle Fave, Gianfranco, Tesselaar, Margot E., Wolin, Edward, Van Cutsem, Eric, Tomassetti, Paola, Strosberg, Jonathan, Voi, Maurizio, Bubuteishvili‐Pacaud, Lida, Ridolfi, Antonia, Herbst, Fabian, Tomasek, Jiri, Singh, Simron, Pavel, Marianne, Kulke, Matthew H., Valle, Juan W., Yao, James C.
Published in Cancer Sci (2017)

Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms

by Grimaldi, Franco, Fazio, Nicola, Attanasio, Roberto, Frasoldati, Andrea, Papini, Enrico, Angelini, Francesco, Baldelli, Roberto, Berretti, Debora, Bianchetti, Sara, Bizzarri, Giancarlo, Caputo, Marco, Castello, Roberto, Cremonini, Nadia, Crescenzi, Anna, Davì, Maria Vittoria, D’Elia, Angela Valentina, Faggiano, Antongiulio, Pizzolitto, Stefano, Versari, Annibale, Zini, Michele, Rindi, Guido, Öberg, Kjell
Published 2014

Dual modulation of MCL-1 and mTOR determines the response to sunitinib

by Elgendy, Mohamed, Abdel-Aziz, Amal Kamal, Renne, Salvatore Lorenzo, Bornaghi, Viviana, Procopio, Giuseppe, Colecchia, Maurizio, Kanesvaran, Ravindran, Toh, Chee Keong, Bossi, Daniela, Pallavicini, Isabella, Perez-Gracia, Jose Luis, Lozano, Maria Dolores, Giandomenico, Valeria, Mercurio, Ciro, Lanfrancone, Luisa, Fazio, Nicola, Nole, Franco, Teh, Bin Tean, Renne, Giuseppe, Minucci, Saverio
Published in J Clin Invest (2016)

Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study

by Fazio, Nicola, Gervaso, Lorenzo, Halfdanarson, Thorvardur R., La Salvia, Anna, Hofland, Johannes, Hernando, Jorge, Sonbol, Mohamad B., Garcia-Carbonero, Rocio, Capdevila, Jaume, de Herder, Wouter W., Koumarianou, Anna, Kaltsas, Gregory, Rossi, Maura, Grozinsky-Glasberg, Simona, Oleinikov, Kira, Boselli, Sabrina, Tamayo, Darina, Bagnardi, Vincenzo, Laffi, Alice, Rubino, Manila, Spada, Francesca
Published in Eur J Cancer (2021)

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24–25 June 2014, Milan

by Bouche, Gauthier, André, Nicolas, Banavali, Shripad, Berthold, Frank, Berruti, Alfredo, Bocci, Guido, Brandi, Giovanni, Cavallaro, Ugo, Cinieri, Saviero, Colleoni, Marco, Curigliano, Giuseppe, Desidero, Teresa Di, Eniu, Alexandru, Fazio, Nicola, Kerbel, Robert, Hutchinson, Lisa, Ledzewicz, Urszula, Munzone, Elisabetta, Pasquier, Eddy, Graciela Scharovsky, O, Shaked, Yuval, Štěrba, Jaroslav, Villalba, Martin, Bertolini, Francesco
Published 2014

Everolimus for the treatment of advanced, nonfunctional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

by Yao, James C, Fazio, Nicola, Singh, Simron, Buzzoni, Roberto, Carnaghi, Carlo, Wolin, Edward, Tomasek, Jiri, Raderer, Markus, Lahner, Harald, Voi, Maurizio, Pacaud, Lida Bubuteishvili, Rouyrre, Nicolas, Sachs, Carolin, Valle, Juan W, Fave, Gianfranco Delle, Van Cutsem, Eric, Tesselaar, Margot, Shimada, Yasuhiro, Oh, Do-Youn, Strosberg, Jonathan, Kulke, Matthew H, Pavel, Marianne E
Published in Lancet (2015)

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors

by Berardi, Rossana, Torniai, Mariangela, Pusceddu, Sara, Spada, Francesca, Ibrahim, Toni, Brizzi, Maria Pia, Antonuzzo, Lorenzo, Ferolla, Piero, Panzuto, Francesco, Silvestris, Nicola, Partelli, Stefano, Ferretti, Benedetta, Freddari, Federica, Gucciardino, Calogero, Testa, Enrica, Concas, Laura, Murgioni, Sabina, Bongiovanni, Alberto, Zichi, Clizia, Riva, Nada, Rinzivillo, Maria, Brunetti, Oronzo, Giustini, Lucio, Di Costanzo, Francesco, Delle Fave, Gianfranco, Fazio, Nicola, De Braud, Filippo, Falconi, Massimo, Cascinu, Stefano
Published in Cancer Med (2017)

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management

by Oberg, Kjell, Krenning, Eric, Sundin, Anders, Bodei, Lisa, Kidd, Mark, Tesselaar, Margot, Ambrosini, Valentina, Baum, Richard P, Kulke, Matthew, Pavel, Marianne, Cwikla, Jaroslaw, Drozdov, Ignat, Falconi, Massimo, Fazio, Nicola, Frilling, Andrea, Jensen, Robert, Koopmans, Klaus, Korse, Tiny, Kwekkeboom, Dik, Maecke, Helmut, Paganelli, Giovanni, Salazar, Ramon, Severi, Stefano, Strosberg, Jonathan, Prasad, Vikas, Scarpa, Aldo, Grossman, Ashley, Walenkamp, Annemeik, Cives, Mauro, Virgolini, Irene, Kjaer, Andreas, Modlin, Irvin M
Published in Endocr Connect (2016)